Bonumose is a pioneering early-stage food ingredient manufacturer, aiming to revolutionize the mass market with its affordable production of healthy, rare sugars. Founded in 2016 and headquartered in the United States, the company is making its mark by leveraging innovative, enzymatic technology discovered by Dr. Daniel Wichelecki, enabling commercial-scale production of naturally-occurring sugars like tagatose and allulose.
These "good-for-you" sugars offer significant health benefits and are designed to meet the increased consumer demand for tasty yet healthy ingredients without the typical financial or nutritional drawbacks. With a similar taste and technical profile to common sugars, they can seamlessly integrate into a wide range of food and beverage products, promoting healthy teeth, glycemic control, and improved gut health.
Recently, Bonumose secured a $34.68M Late VC investment as of 01 October 2023, signaling strong confidence from investors in its growth potential and innovative approach.